Get the Stockscreener App
15.38
1.25%
0.19
After Hours:
15.38
Core Laboratories Inc Stock (CLB) Latest News
Core Laboratories Inc. (NYSE:CLB) Shares Sold by Bank of New York Mellon Corp - MarketBeat
Tecsys Expands Global Reach with Roche's Adoption of Elite™ for Laboratory Inventory Management - Financial Times
Royce & Associates LP Has $16.78 Million Stake in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Wintrust Investments LLC Sells 28,549 Shares of Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Assetmark Inc. Acquires New Holdings in Core Laboratories Inc. (NYSE:CLB) - Defense World
Bank of New York Mellon Corp Reduces Stock Position in Core Laboratories Inc. (NYSE:CLB) - Defense World
Core Laboratories (NYSE:CLB) Rating Increased to Neutral at Citigroup - MarketBeat
Core Laboratories (NYSE:CLB) Raised to “Neutral” at Citigroup - Defense World
Core Laboratories Inc. (NYSE:CLB) Shares Purchased by Smartleaf Asset Management LLC - Defense World
Jones Financial Companies Lllp Has $284,000 Holdings in Core Laboratories Inc. (NYSE:CLB) - Defense World
Citigroup Upgrades Core Laboratories (CLB) - Nasdaq
Core Labs raised at Citi as further negative revision risk seen as minimal (CLB:NYSE) - Seeking Alpha
Tesla To $120? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $16 From $15 - Marketscreener.com
Balanced Risk/Reward Outlook for Core Laboratories Amidst Decline and Growth Opportunities - TipRanks
Citi raises Core Laboratories stock rating, target to $16 By Investing.com - Investing.com Canada
Core Laboratories (NYSE:CLB) Reaches New 12-Month LowTime to Sell? - MarketBeat
Fisher Asset Management LLC Has $16.29 Million Stock Position in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Core Laboratories (NYSE:CLB) Stock Price Down 4.9%Here's What Happened - MarketBeat
Zephirin Adjusts Price Target on Core Laboratories to $18 From $22, Maintains Buy Rating - Marketscreener.com
The three-year underlying earnings growth at Core Laboratories (NYSE:CLB) is promising, but the shareholders are still in the red over that time - Simply Wall St
Principal Financial Group Inc. Grows Position in Core Laboratories Inc. (NYSE:CLB) - Defense World
Core Laboratories (NYSE:CLB) Hits New 52-Week LowTime to Sell? - MarketBeat
Rhumbline Advisers Decreases Stake in Core Laboratories Inc. (NYSE:CLB) - Defense World
Is Core Stock Worth Buying After a 27% Surge in 6 Months? - Nasdaq
Why Is Core Laboratories (CLB) Down 16% Since Last Earnings Report? - Yahoo Finance
Dividend Coverage: This Energy Services Company has a Dividend Yield of 2.32%; Will Trade Ex-Dividend on October 19, 2017 - ACCESS Newswire
Core Laboratories stock hits 52-week low at $14.61 - Investing.com
Citigroup Forecasts Strong Price Appreciation for Core Laboratories (NYSE:CLB) Stock - MarketBeat
Kornitzer Capital Management Inc. KS Purchases Shares of 35,515 Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Van ECK Associates Corp Acquires 26,237 Shares of Core Laboratories Inc. (NYSE:CLB) - MarketBeat
The past five years for Core Laboratories (NYSE:CLB) investors has not been profitable - Yahoo Finance
Rice Hall James & Associates LLC Buys New Shares in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
Van ECK Associates Corp Boosts Stock Holdings in Core Laboratories Inc. (NYSE:CLB) - Defense World
Core Laboratories Inc. /DE/ SEC 10-K Report - TradingView
Core Laboratories Inc. (NYSE:CLB) Stock Holdings Lifted by Boston Trust Walden Corp - MarketBeat
Core Laboratories Inc (CLB) Stock: Understanding the Volatility - The News Heater
SG Americas Securities LLC Has $411,000 Stock Position in Core Laboratories Inc. (NYSE:CLB) - MarketBeat
3.30%
1.60%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):